![Benedikt Stefansson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benedikt Stefansson
Investor Relations Contact chez ALVOTECH
Postes actifs de Benedikt Stefansson
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALVOTECH | Investor Relations Contact | 02/03/2022 | - |
Public Communications Contact | 02/03/2022 | - |
Historique de carrière de Benedikt Stefansson
Anciens postes connus de Benedikt Stefansson
Sociétés | Poste | Début | Fin |
---|---|---|---|
CRI hf.
![]() CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Corporate Officer/Principal | - | - |
deCODE genetics, Inc.
![]() deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Sales & Marketing | - | - |
Landsbanki Research | Analyst-Equity | - | - |
Formation de Benedikt Stefansson
University of California, Los Angeles | Graduate Degree |
Statistiques
Internationale
Islande | 4 |
Etats-Unis | 2 |
Luxembourg | 2 |
Opérationnelle
Analyst-Equity | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Process Industries | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALVOTECH | Health Technology |
Entreprise privées | 3 |
---|---|
Landsbanki Research | |
CRI hf.
![]() CRI hf. Chemicals: SpecialtyProcess Industries CRI hf. captures carbon dioxide from industrial emissions and converts carbon dioxide into renewable methanol. It produces renewable methanol from carbon dioxide, hydrogen and electricity for energy storage, fuel applications and enhancement. The firm serves the following industries: bio diesel production, chemicals, gasoline blending, and wastewater treatment industries. Its services include project partnership, feasibility to investment, project execution, and lifetime operation services. The company was founded by Oddur Ingólfsson, Arthur Shulenberger, Fridrik Jonsson, and K-C Tran in 2006 and is headquartered in Kopavogur, Iceland. | Process Industries |
deCODE genetics, Inc.
![]() deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Bourse
- Insiders
- Benedikt Stefansson
- Expérience